Document ID: chunk:federal_register_of_legislation:F2025C00124:clause:3_1:p242
Version: federal_register_of_legislation:F2025C00124
Segment Type: clause
Provision Reference: sch 3 cl 1 (pt 242/476)
Character Range: 2319365–2332774

triple therapy (this drug, bortezomib and dexamethasone) for treatment cycles 5 and 6 (administered using 28‑day treatment cycles)
                                                                                                                                            Patient must have received PBS‑subsidised treatment with this drug under the treatment phase covering cycles 1 to 4; AND
                                                                                                                                            The treatment must form part of triple combination therapy limited to: (i) this drug, (ii) bortezomib, (iii) dexamethasone; AND
                                                                                                                                            The treatment must not exceed a total of 2 cycles under this restriction.
                                                                       C14362                                                               Relapsed and/or refractory multiple myeloma                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Compliance with Authority Required procedures
                                                                                                                                            Triple combination therapy consisting of carfilzomib, lenalidomide and dexamethasone
                                                                                                                                            Patient must be undergoing concurrent treatment with carfilzomib obtained through the PBS; AND
                                                                                                                                            Patient must not be undergoing simultaneous treatment with this drug obtained under another PBS listing.
Levodopa with carbidopa                                                C10138              P10138                                           Advanced Parkinson disease                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Compliance with Authority Required procedures ‑ Streamlined Authority Code 10138
                                                                                                                                            Patient must have severe disabling motor fluctuations not adequately controlled by oral therapy; AND
                                                                                                                                            The treatment must be commenced in a hospital‑based movement disorder clinic.
                                                                       C10161              P10161                                           Advanced Parkinson disease                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Compliance with Authority Required procedures ‑ Streamlined Authority Code 10161
                                                                                                                                            Patient must have severe disabling motor fluctuations not adequately controlled by oral therapy; AND
                                                                                                                                            The treatment must be commenced in a hospital‑based movement disorder clinic.
                                                                       C10363              P10363                                           Advanced Parkinson disease                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Compliance with Authority Required procedures ‑ Streamlined Authority Code 10363
                                                                                                                                            Patient must have severe disabling motor fluctuations not adequately controlled by oral therapy; AND
                                                                                                                                            The treatment must be commenced in a hospital‑based movement disorder clinic; AND
                                                                                                                                            Patient must require continuous administration of levodopa without an overnight break; OR
                                                                                                                                            Patient must require a total daily dose of more than 2000 mg of levodopa.
                                                                       C10375              P10375                                           Advanced Parkinson disease                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Compliance with Authority Required procedures ‑ Streamlined Authority Code 10375
                                                                                                                                            Patient must have severe disabling motor fluctuations not adequately controlled by oral therapy; AND
                                                                                                                                            The treatment must be commenced in a hospital‑based movement disorder clinic; AND
                                                                                                                                            Patient must require continuous administration of levodopa without an overnight break; OR
                                                                                                                                            Patient must require a total daily dose of more than 2000 mg of levodopa.
Lipegfilgrastim                                                        C7822                                                                Chemotherapy‑induced neutropenia                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      Compliance with Authority Required procedures ‑ Streamlined Authority Code 7822
                                                                                                                                            Patient must be receiving chemotherapy with the intention of achieving a cure or a substantial remission; AND
                                                                                                                                            Patient must be at greater than 20% risk of developing febrile neutropenia; OR
                                                                                                                                            Patient must be at substantial risk (greater than 20%) of prolonged severe neutropenia for more than or equal to seven days.
                                                                       C7843                                                                Chemotherapy‑induced neutropenia                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      Compliance with Authority Required procedures ‑ Streamlined Authority Code 7843
                                                                                                                                            Patient must be receiving chemotherapy with the intention of achieving a cure or a substantial remission; AND
                                                                                                                                            Patient must have had a prior episode of febrile neutropenia; OR
                                                                                                                                            Patient must have had a prior episode of prolonged severe